| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D001151 |
Arsenic |
Arsenic results in increased methylation of PRSS3 promoter | increases methylation | 15987713
|
| C055494 |
caffeic acid phenethyl ester |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PRSS3 mRNA | affects cotreatment|decreases expression | 20360939
|
| D003520 |
Cyclophosphamide |
PRSS3 protein affects the susceptibility to Cyclophosphamide | affects response to substance | 16217747
|
| D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PRSS3 mRNA | affects cotreatment|decreases expression | 20360939
|
| C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PRSS3 mRNA | affects binding|decreases expression|increases activity | 19710929
|
| C079198 |
S 1 (combination) |
PRSS3 protein results in increased susceptibility to S 1 (combination) | increases response to substance | 16734730
|
| D014302 |
Trinitrobenzenesulfonic Acid |
Trinitrobenzenesulfonic Acid results in increased expression of PRSS3 mRNA | increases expression | 17982090
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.42 | 18653653 |
| MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.99 | 10737359 6695378 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
11.45 | 17162532 19061943 18056438 19052882 16434500 17620307 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
11.45 | 16434500 |
| MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
5.66 | 17306315 |
| MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.93 | 18414634 12569548 16251483 16835338 |
| MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
4.96 | 15014928 |
| MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.40 | 19371607 12928151 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.43 | 19483382 |
| MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
2.41 | 12006526 18323546 15136595 11325840 16978400 18234424 15093573 17388661 17020986 |
| MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.41 | 17474063 |
| MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.73 | 17687452 15504454 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
4.96 | 16507464 17306315 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
4.96 | 19701751 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
4.96 | 16328049 16698587 19418558 21159647 18971187 17428255 17055752 20524982 19052882 20084675 20727157 19701751 17978847 19519916 16569478 18785209 18506893 18056438 16935385 3581430 18665156 16779866 16288022 18393292 20214788 19539802 19107877 20007298 17761372 16830150 19208518 16540662 16878318 20935162 20432363 19394651 10737359 11831363 17173139 16807293 18494052 18978308 20514400 19822196 3084413 19335982 17162532 16681979 10672840 20101231 19383236 19919837 20512989 18788625 19171122 16502159 18691550 18210153 17138121 |
| MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
5.28 | 16152834 |
| MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
S 1 (combination) |
4.15 | 18212800 18347146 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
3.65 | 16201981 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
5.60 | 15504454 17687452 18922899 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
S 1 (combination) |
5.60 | 15984520 |
| MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
4.34 | 18640142 |
| MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
3.63 | 15738583 17938729 19152805 |
| MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.56 | 16973168 18022660 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
3.04 | 7505956 21159647 2727394 17174075 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.93 | 19052882 |
| MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.03 | 19176532 |
| MESH:D003092 |
Colitis |
|
Trinitrobenzenesulfonic Acid |
4.90 | 18200517 16782535 16867261 16804969 17936198 11698051 17991707 16474422 18023891 |
| MESH:D003093 |
Colitis, Ulcerative |
|
Trinitrobenzenesulfonic Acid |
3.52 | 17276891 |
| MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
5.43 | 18093676 17979934 10498854 18483878 18433785 18372110 12913760 16413132 18295254 16989017 16614059 12388444 15643279 18710439 15276878 11948286 17010015 10700343 16651033 12161096 |
| MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.53 | 18249437 |
| MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
4.30 | 15331540 11751995 10990075 |
| MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.29 | 18772604 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.24 | 20387270 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
2.12 | 19107877 |
| MESH:D004487 |
Edema |
|
pirinixic acid |
2.76 | 12083418 |
| MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.57 | 11006010 |
| MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.56 | 16302075 |
| MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
8.63 | 20387270 21071580 |
| MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.63 | 20131406 19236843 |
| MESH:D005355 |
Fibrosis |
|
Trinitrobenzenesulfonic Acid |
4.71 | 17994277 |
| MESH:D005534 |
Foot Diseases |
|
Arsenic |
6.00 | 6392382 |
| MESH:D005706 |
Gallbladder Neoplasms |
|
S 1 (combination) |
6.09 | 19093184 |
| MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.91 | 11389073 |
| MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
5.39 | 16376943 11014644 15172196 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
S 1 (combination) |
4.92 | 15984520 18607998 |
| MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.69 | 20558911 |
| MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.65 | 11918545 |
| MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.98 | 14986274 |
| MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.35 | 16221962 19176532 18467677 19772884 |
| MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
4.03 | 17606976 16135485 |
| MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.45 | 20558911 |
| MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.72 | 17050553 |
| MESH:D006973 |
Hypertension |
|
Arsenic |
2.95 | 9931084 11953799 16076760 |
| MESH:D006987 |
Hypesthesia |
|
Arsenic |
6.00 | 16093927 |
| MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.77 | 16076520 |
| MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
3.79 | 7193160 16517039 |
| MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
2.50 | 18785209 |
| MESH:D015212 |
Inflammatory Bowel Diseases |
|
Trinitrobenzenesulfonic Acid |
3.67 | 18200517 |
| MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.80 | 16306350 |
| MESH:D007410 |
Intestinal Diseases |
|
Trinitrobenzenesulfonic Acid |
4.96 | 17994277 |
| MESH:D007414 |
Intestinal Neoplasms |
|
caffeic acid phenethyl ester |
4.85 | 10783313 |
| MESH:D007642 |
Keratosis |
|
Arsenic |
5.39 | 16930632 12749816 |
| MESH:D007674 |
Kidney Diseases |
|
caffeic acid phenethyl ester |
3.69 | 15369732 |
| MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
3.61 | 10602166 |
| MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.59 | 17008537 17296974 17658394 18587576 18172266 17802794 |
| MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
4.29 | 10373061 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
8.64 | 17339181 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
caffeic acid phenethyl ester |
8.64 | 16766008 |
| MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
5.36 | 10052129 11830472 |
| MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.96 | 18665156 19638242 18522880 18407596 20032147 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
| MESH:D008107 |
Liver Diseases |
|
Arsenic |
4.44 | 11134558 |
| MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
4.44 | 17034775 |
| MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
7.99 | 16368122 |
| MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
7.99 | 20101389 19427195 18754104 2862719 18977376 19690152 19638242 20492335 19551842 19255062 15885732 19833225 12112319 21047994 20118626 10737359 19294768 21167192 19812893 19426721 18644402 19996281 19090486 19256749 20137499 20583210 12771043 19073162 19254457 21071580 20434301 19642983 21278145 9163691 15175105 20405173 20452335 16942905 18978307 2422723 19499222 18648771 19850985 20501860 |
| MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.99 | 15890375 20007298 16377806 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
2.79 | 2563599 18164116 21159647 19126423 19009564 18282651 17854601 9362446 18544905 19519916 18775883 16842330 18079962 17942915 17174075 18253720 19539802 18093689 16267830 18308698 19004024 3124819 |
| MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
2.67 | 17976673 17306315 19168569 |
| MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
2.67 | 20512841 20970405 21163286 6695378 |
| MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
4.03 | 12854902 |
| MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.90 | 16675587 |
| MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
4.40 | 11911406 |
| MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
5.16 | 16388313 |
| MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.86 | 16239165 |
| MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.24 | 19151258 |
| MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
4.21 | 15371236 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.16 | 16411023 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.66 | 3581430 9029167 |
| MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
5.58 | 18854779 |
| MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.58 | 17405874 |
| MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
3.62 | 16620997 |
| MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
3.76 | 16115947 15176712 8761367 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.57 | 20387270 |
| MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
5.28 | 8761367 12837982 |
| MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.68 | 17056641 |
| MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.56 | 20387270 |
| MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.63 | 8291058 |
| MESH:D009765 |
Obesity |
|
pirinixic acid |
1.86 | 20558911 |
| MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
5.11 | 16517039 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
2.81 | 17306315 |
| MESH:D010146 |
Pain |
|
Cyclophosphamide |
3.85 | 12161096 18093676 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
5.79 | 11332152 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
5.79 | 16540662 |
| MESH:D010195 |
Pancreatitis |
|
Trinitrobenzenesulfonic Acid |
4.50 | 17698068 |
| MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.51 | 16093927 |
| MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
5.39 | 6392382 15371236 16905509 |
| MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.80 | 2563599 |
| MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.94 | 21297632 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
3.59 | 16140617 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
3.59 | 17136230 |
| MESH:D011507 |
Proteinuria |
|
Arsenic |
4.31 | 21343184 |
| MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.37 | 16636934 |
| MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.50 | 19058328 |
| MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
5.13 | 16636934 |
| MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.80 | 18709164 16759981 19834688 17548696 17938729 15952646 6392382 17453740 17050553 16353154 16702368 |
| MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
3.12 | 17976673 15504454 17050553 19538983 16251483 17029826 |
| OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.91 | 16517039 |
| MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
3.05 | 18456281 |
| MESH:D013274 |
Stomach Neoplasms |
|
S 1 (combination) |
3.05 | 18506536 16557585 18553229 |
| MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
5.45 | 12837982 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.19 | 7505956 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
marker/mechanism |
|
| 15987713 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
5.83 | 19429237 17976673 15987713 11144890 18640142 19322015 17306315 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
5.83 | 14692829 |
| MESH:D014652 |
Vascular Diseases |
|
Arsenic |
5.13 | 17056641 |